HIGH

Boothwyn Pharmacy Recalls Semaglutide Injection for Subpotency

Boothwyn Pharmacy recalled 642 vials of Semaglutide injection on July 9, 2025. The recall follows the discovery that the drug is subpotent. Consumers should stop using the product immediately and seek guidance from healthcare providers.

Quick Facts at a Glance

Recall Date
July 9, 2025
Hazard Level
HIGH
Brand
Boothwyn Pharmacy
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Subpotent Drug

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Boothwyn Pharmacy LLC or your healthcare provider for guidance. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Product Details

The recalled product is Semaglutide, 2.5 mg/mL injection, 2 mL vials. Model numbers include 03202025@5, 03202025@6, 03202025@7, and 03202025@8 with a BUD of 07/18/2025. The product was distributed nationwide in the U.S.

The Hazard

The recall is classified as Class II due to the subpotency of the drug. Subpotent medications may not provide the intended therapeutic effect, which can lead to inadequate treatment of conditions.

Reported Incidents

No specific injury or incident reports are mentioned. The recall is in response to the identified issue of subpotency.

What to Do

Stop using the Semaglutide injection immediately. Contact Boothwyn Pharmacy LLC or your healthcare provider for further guidance.

Contact Information

For more information, visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0606-2025.

Key Facts

  • Recall date: July 9, 2025
  • Quantity: 642 vials
  • Class II recall due to subpotency
  • Distributed nationwide in the U.S.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
03202025@5
03202025@6
03202025@7
03202025@8 BUD 07/18/2025
Affected States
ALL
Report Date
September 10, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

HIGH

Acuity Specialty Products Recalls Hand Sanitizer Due to Methanol Risk

Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.

Acuity Specialty Products
cGMP deviations:
Read more
HIGH

AFCO Hand Sanitizer Recalled Due to Methanol Risk

AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.

AFCO
cGMP deviations:
Read more